Friday, Jul 24, 2026 The claims desk. Receipts included. POWERED BY LENZ ↗
IsThis

GENERAL

The Claim

Isoniazid mono-resistant tuberculosis has a documented and measurable prevalence in Ethiopia as of April 2026.

Verified by Lenz ·

The Short Version

Multiple peer-reviewed, nationally representative studies published in 2025 — including Ethiopia's Third National TB Drug Resistance Survey — quantify isoniazid mono-resistant TB prevalence at approximately 4.1% among new cases. These constitute documented, measurable prevalence data that remain the authoritative reference as of April 2026, with no contradicting evidence suggesting elimination or significant change. Variation across studies (0.9%–6.23%) reflects differences in study populations and methods, not an absence of measurement.

Caveats

  • Prevalence estimates vary by region and study population (e.g., national surveys report ~4.1%, a single-hospital study reports 0.9%, and a meta-analysis reports 6.23%), so the specific figure depends on the population and methodology referenced.
  • The most recent data derive from surveys conducted before April 2026; no real-time surveillance figure exists at that exact date, though published 2025 national survey data represents the standard epidemiological reference.
  • LLM-generated background knowledge (Source 15) is not an independently verifiable source and should not be relied upon for precise epidemiological claims.

The Receipts

  1. The Ethiopian Third National Tuberculosis Drug Resistance Survey Incorporating Whole Genome Sequencing - PMC

    pmc.ncbi.nlm.nih.gov

  2. Isoniazid-resistant TB and associated factors in Ethiopia - PubMed - NIH

    pubmed.ncbi.nlm.nih.gov

  3. The Ethiopian Third National Tuberculosis Drug Resistance Survey Incorporating Whole Genome Sequencing - PubMed

    PubMed

  4. Isoniazid-resistant TB and associated factors in Ethiopia - PMC

    pmc.ncbi.nlm.nih.gov

  5. Mycobacterium tuberculosis Drug Resistance in Ethiopia: An Updated Systematic Review and Meta-Analysis - PMC

    pmc.ncbi.nlm.nih.gov

  6. Prevalence of drug-resistant Mycobacterium tuberculosis and its associated factors among tuberculosis patients attending Dilla university referral hospital, Ethiopia - PubMed

    PubMed

  7. Prevalence of drug-resistant Mycobacterium tuberculosis and its associated factors among tuberculosis patients attending Dilla university referral hospital, Ethiopia - PMC

    PMC

  8. Mycobacterium tuberculosis Drug Resistance in Ethiopia: An Updated Systematic Review and Meta-Analysis - PubMed

    PubMed

  9. “Yes! We Can End TB!” — WHO Calls for Accelerated Implementation of the Multisectoral Accountability Framework for the TB Response

    afro.who.int

  10. Surveillance of drug resistance tuberculosis based on reference ...

    DOAJ

+ 4 more sources — see the full list on Lenz